/Companies

OtoNexus Medical Technologies

Seattle, US · Delaware corporation · 3 known investors

Find your way into OtoNexus Medical Technologies

Sign up to see every warm intro you have to OtoNexus Medical Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the OtoNexus Medical Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CCCaitlin Cameron
Caitlin CameronExecutive
MA
Mark A. MoehringNamed on SEC filing
GA
George A. GatesNamed on SEC filing

Board

HB
Harris BrodyBoard director
RF
Rhonda F. RhyneBoard director
MR
Marion R. FooteBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$44.3M disclosed across 5 rounds · 2015–2022

▶$12.9MraisedFeb 2024 · 114 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark A. MoehringDirector
  • Marion R. FooteDirector
  • George A. GatesExecutive Officer, Director
  • Caitlin CameronExecutive Officer, Director
  • Harris BrodyDirector
Offering amount
$15M
Amount sold
$12.9M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJan 2022 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Harris BrodyDirector
  • Rhonda F. RhyneDirector
  • Caitlin CameronExecutive Officer, Director
  • Marion R. FooteDirector
  • George A. GatesExecutive Officer, Director
  • Mark A. MoehringDirector
Offering amount
$5M
Amount sold
$1.9M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.5MraisedJun 2021 · 190 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
  • George A. GatesExecutive Officer, Director
  • Rhonda F. RhyneDirector
  • Harris BrodyDirector
  • Mark A. MoehringDirector
Offering amount
$28.2M
Amount sold
$19.5M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedJan 2017 · 80 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rhonda F. RhyneDirector
  • Mark A. MoehringDirector
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
  • George A. GatesExecutive Officer, Director
  • Harris BrodyDirector
Offering amount
$9.2M
Amount sold
$7.8M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2016 · 54 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark A. MoehringDirector
  • Harris BrodyDirector
  • Rhonda F. RhyneDirector
  • George A. GatesExecutive Officer, Director
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2.2M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are OtoNexus Medical Technologies's investors?
OtoNexus Medical Technologies's investors include Dellin Investments, Keiretsu Capital, Keiretsu Forum.
How much funding has OtoNexus Medical Technologies raised?
OtoNexus Medical Technologies has disclosed $44.3M raised across 5 rounds.
Where is OtoNexus Medical Technologies headquartered?
OtoNexus Medical Technologies is headquartered in Seattle, US.